SENSEX 76171.08 (-0.16)
Nifty 50 23045.25 (-0.12)
Nifty Bank 49479.45 (0.15)
Nifty IT 41733 (-0.56)
Nifty Midcap 100 50756.4 (-0.26)
Nifty Next 50 60826.5 (0.00)
Nifty Pharma 21142.05 (-0.51)
Nifty Smallcap 100 16033 (-0.26)
NIKKEI 225 38963.7 (0.42)
HANG SENG 21857.92 (2.64)
S&P 6095 (-0.15)
BSE Code : 524816 | NSE Symbol : NATCOPHARM | ISIN : INE987B01026 | Industry : Pharmaceuticals |
Hot Pursuit 10-Feb-2025 (10:39) NATCO Pharma gets final approval for its ANDA for Bosentan tablets
Corporate News 10-Feb-2025 (09:16) Natco Pharma receives USFDA approval for Bosentan tablets for oral suspension, 32mg
Hot Pursuit 06-Feb-2025 (13:06) Natco Pharma Ltd soars 3.15%, up for third straight session
Corporate News 31-Jan-2025 (10:24) Natco Pharma to hold board meeting
Hot Pursuit 30-Jan-2025 (12:57) NATCO Pharma gets approval for its ANDA for Everolimus tablets
Natco Pharma 13-Nov-2024
Natco Pharma 13-Aug-2024
Natco Pharma 28-May-2024
Total Foreign
Total Institutions
Total Govt Holding
Total Non Promoter Corporate Holding
Total Promoters
Total Public & others